Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 29;19(21):14154.
doi: 10.3390/ijerph192114154.

Mandibular Torus as a New Index of Success for Mandibular Advancement Devices

Affiliations

Mandibular Torus as a New Index of Success for Mandibular Advancement Devices

Teresa Diaz de Teran et al. Int J Environ Res Public Health. .

Abstract

Background: In obstructive sleep apnoea (OSA), treatment with mandibular advancement devices (MADs) reduces patients' Apnoea-Hypopnoea index (AHI) scores and improves their sleepiness and quality of life. MADs are non-invasive alternatives for patients who cannot tolerate traditional continuous positive airway pressure (CPAP) therapy. The variability of responses to these devices makes it necessary to search for predictors of success. The aim of our study was to evaluate the presence of mandibular torus as a predictor of MAD efficacy in OSA and to identify other potential cephalometric factors that could influence the response to treatment.

Methods: This was a retrospective cohort study. The study included 103 patients diagnosed of OSA who met the criteria for initiation of treatment with MAD. Structural variables were collected (cephalometric and the presence or absence of mandibular torus). Statistical analysis was performed to evaluate the existence of predictive factors for the efficacy of MADs.

Results: A total of 103 patients who were consecutively referred for treatment with MAD were included (89.3% men); the mean age of the participants was 46.3 years, and the mean AHI before MAD was 31.4 (SD 16.2) and post- MAD 11.3 (SD 9.2). Thirty-three percent of patients had mandibular torus. Torus was associated with a better response (odds ratio (OR) = 2.854 (p = 0.035)) after adjustment for sex, age, body mass index (BMI; kg/m2), the angle formed by the occlusal plane to the sella-nasion plane (OCC plane to SN), overinjection, and smoking. No cephalometric predictors of efficacy were found that were predictive of MAD treatment success.

Conclusions: The presence of a mandibular torus practically triples the probability of MAD success. This is the simplest examination with the greatest benefits in terms of the efficacy of MAD treatment for OSA.

Keywords: cephalometry; mandibular advancement devices; mandibular torus; obstructive sleep apnoea.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Sagittal cephalometric view showing the reference parameters (points, planes, angles, and Cartesian coordinates) used in the study. Cephalometric points. Na: nasion, most anterior point of the fronto-nasal suture; S: sella, geometric centre of the sella turcica; Eb: base of the epiglottis; H: most anterior point of the body of the hyoid bone; TT: tip of the tongue; RGn: most posterior point of mandibular symphysis at the level of the mid-sagittal plane; CV4IP: most inferior point of the C4; Co: most anterior and superior point of the mandibular condyle; Gn: most anterior and inferior point of the mandible at the level of the mid-sagittal plane of the symphysis; B: most posterior point of the anterior concavity of the mandibular symphysis; Go: most posteroinferior point of the mandible; A: most posterior point of the anterior concavity of the maxillary bone. Me: inferior most point of mandibular symphysis. Po: most superior point of the external auditory canal.
Figure 2
Figure 2
Mandibular torus.
Figure 3
Figure 3
Patient flow chart.
Figure 4
Figure 4
ROC Curve Model 1.
Figure 5
Figure 5
Lateral neck X-ray of one of our patients showing Hyoid-C3 vertebra distance.

References

    1. Sullivan C.E., Issa F.G., Berthon-Jones M., Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1:862–865. doi: 10.1016/S0140-6736(81)92140-1. - DOI - PubMed
    1. Marklund M., Verbraecken J., Randerath W. Non-CPAP therapies in obstructive sleep apnoea: Mandibular advancement device therapy. Eur. Respir. J. 2012;39:1241–1247. doi: 10.1183/09031936.00144711. - DOI - PubMed
    1. Cobo J., Canut J.A., Carlos F., Vijande M., Llamas J.M. Changes in the upper airway of patients who wear a modified functional appliance to treat obstructive sleep apnea. Int. J. Adult Orthodon. Orthognath. Surg. 1995;10:53–57. - PubMed
    1. Ryan C.F., Love L.L., Peat D., Fleetham J.A., Lowe A.A. Mandibular advancement oral appliance therapy for obstructive sleep apnoea: Effect on awake calibre of the velopharynx. Thorax. 1999;54:972–977. doi: 10.1136/thx.54.11.972. - DOI - PMC - PubMed
    1. Okuno K., Pliska B.T., Hamoda M., Lowe A.A., Almeida F.R. Prediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review. Sleep Med. Rev. 2016;30:25–33. doi: 10.1016/j.smrv.2015.11.007. - DOI - PubMed

LinkOut - more resources